First Trust NASDAQ Cybersecurity ETF vs Medpace Holdings Inc — how do they compare? First Trust NASDAQ Cybersecurity ETF trades at $100.19, while Medpace Holdings Inc trades at $600.79 (market cap $16.90B). Which is the better fit depends on your goals.
| CIBR | MEDP | |
|---|---|---|
52-Week High | $100.60 | $620.59 |
52-Week Low | $60.74 | $393.42 |
Market Cap | — | $16.90B |
Sector | — | Technology |
Enterprise Value | — | $16.52B |
Signals from Pluang's Aura AI — not financial advice
CIBR trades at $99.87, down 0.73% today, with a bullish technical signal from moving averages but overbought RSI readings. The ETF has outperformed the S&P 500 year-to-date, driven by strong cybersecurity spending trends exceeding $300 billion in 2026. Recent news highlights institutional activity, including Bank of America reducing its stake while First Trust Advisors increased its position.
The outlook remains positive due to secular growth in cybersecurity demand, though high RSI levels suggest near-term consolidation risk. Key opportunities include AI-driven security expansion, while risks involve sector concentration and market volatility. Analyst sentiment is generally bullish, with upgrades citing reasonable valuations and strong momentum.
MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.
Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.
Trailing returns across standard periods
Latest headlines on both assets
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as cyber security companies. The fund is non-diversified.
Read more on CIBR →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →